Immunic (IMUX) Competitors

SIGA Technologies (NASDAQ:SIGA) and Immunic (NASDAQ:IMUX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, community ranking, risk, institutional ownership, earnings and analyst recommendations.

Which has more volatility and risk, SIGA or IMUX?

SIGA Technologies has a beta of 0.98, indicating that its share price is 2% less volatile than the S&P 500. Comparatively, Immunic has a beta of 1.89, indicating that its share price is 89% more volatile than the S&P 500.

Does the media refer more to SIGA or IMUX?

In the previous week, SIGA Technologies had 10 more articles in the media than Immunic. MarketBeat recorded 13 mentions for SIGA Technologies and 3 mentions for Immunic. Immunic's average media sentiment score of 0.62 beat SIGA Technologies' score of 0.46 indicating that Immunic is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SIGA Technologies	2 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Immunic	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts recommend SIGA or IMUX?

Immunic has a consensus target price of $12.67, indicating a potential upside of 1,025.93%. Given Immunic's stronger consensus rating and higher possible upside, analysts plainly believe Immunic is more favorable than SIGA Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SIGA Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Immunic	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25

Do institutionals & insiders believe in SIGA or IMUX?

55.4% of SIGA Technologies shares are held by institutional investors. Comparatively, 51.8% of Immunic shares are held by institutional investors. 1.5% of SIGA Technologies shares are held by insiders. Comparatively, 3.0% of Immunic shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Does the MarketBeat Community prefer SIGA or IMUX?

Immunic received 99 more outperform votes than SIGA Technologies when rated by MarketBeat users. Likewise, 64.20% of users gave Immunic an outperform vote while only 23.81% of users gave SIGA Technologies an outperform vote.

Company	Underperform	Outperform
SIGA Technologies	Outperform Votes 5 23.81%	Underperform Votes 16 76.19%
Immunic	Outperform Votes 104 64.20%	Underperform Votes 58 35.80%

Is SIGA or IMUX more profitable?

SIGA Technologies has a net margin of 49.33% compared to Immunic's net margin of 0.00%. SIGA Technologies' return on equity of 49.06% beat Immunic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SIGA Technologies	49.33%	49.06%	38.72%
Immunic	N/A	-169.55%	-118.96%

Which has preferable valuation and earnings, SIGA or IMUX?

SIGA Technologies has higher revenue and earnings than Immunic. Immunic is trading at a lower price-to-earnings ratio than SIGA Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SIGA Technologies	$173.73M	2.27	$68.07M	$1.20	4.61
Immunic	N/A	N/A	-$93.61M	-$1.23	-0.91

Summary

SIGA Technologies and Immunic tied by winning 9 of the 18 factors compared between the two stocks.